Ling Guo

7PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 10, 2026
TQB2618 plus penpulimab, alone or in combination with chemotherapy, for recurrent or metastatic nasopharyngeal carcinoma: a multicentre, two-cohort, phase 2 trial.

|Apr 24, 2026
NMB+CXCL13+CD4+ T Cell-Derived Neuromedin B Promotes Neuropeptide S Receptor 1-Positive Malignant Cell Senescence and Malignancy.

|Mar 31, 2026
Incorporating early cfEBV DNA clearance into clinical risk stratification to tailor induction chemotherapy cycles for locoregionally advanced nasopharyngeal carcinoma.

Wan-Ping Guo, Xuan Yu, Zi-Jian Lu

|Oct 14, 2023
Integrating Baseline Nutritional and Inflammatory Parameters with Post-Treatment EBV DNA Level to Predict Outcomes of Patients with De Novo Metastatic Nasopharyngeal Carcinoma Receiving Chemotherapy Combination PD-1 Inhibitor.

Jia Guo, Qi Yang, Qi Jiang

|Sep 23, 2022
A Prognostic Model Based on Nutritional Risk Index in Operative Breast Cancer.

Fei Lin, Wen Xia, Miao Chen

|Aug 19, 2022
M1 stage subdivisions based on <sup>18</sup>F-FDG PET-CT parameters to identify locoregional radiotherapy for metastatic nasopharyngeal carcinoma.

Hui-Zhi Qiu, Xu Zhang, Sai-Lan Liu

Pageof 2

Frequent Collaborators

1 joint publications

Hui-Zhi Qiu

1 joint publications

Huan-Xin Lin

1 joint publications

Hai-Qiang Mai

1 joint publications

Mingke Yu